XML 26 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS
ASC Topic 820, “Fair Value Measurement,” defines fair value, establishes a framework for measuring fair value including a three‑level valuation hierarchy, and expands disclosures about fair value measurements. Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date reflecting assumptions that a market participant would use when pricing an asset or liability. The hierarchy uses three levels of inputs to measure the fair value of assets and liabilities as follows:
Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2: Observable inputs other than Level 1, including quoted prices for similar assets and liabilities in active markets, quoted prices in less active markets, or other observable inputs that can be corroborated by observable market data, either directly or indirectly, for substantially the full term of the financial instrument. This category generally includes municipal securities, agency residential and commercial MBS, collateralized loan obligations, registered publicly rated private label CMOs and asset-backed securitizations.
Level 3: Inputs to a valuation methodology that are unobservable, supported by little or no market activity, and significant to the fair value measurement. These valuation methodologies generally include pricing models, discounted cash flow models, or a determination of fair value that requires significant management judgment or estimation. This category also includes observable inputs from a pricing service not corroborated by observable market data, and includes our non-rated private label CMOs, non-rated private label asset-backed securities, and equity warrants.
We use fair value to measure certain assets and liabilities on a recurring basis, primarily securities available‑for‑sale and derivatives. For assets measured at the lower of cost or fair value, the fair value measurement criteria may or may not be met during a reporting period and such measurements are therefore considered “nonrecurring” for purposes of disclosing our fair value measurements. Fair value is used on a nonrecurring basis to adjust carrying values for impaired loans and other real estate owned and also to record impairment on certain assets, such as goodwill, CDI, and other long‑lived assets.
The following tables present information on the assets and liabilities measured and recorded at fair value on a recurring basis as of the dates indicated:
 
Fair Value Measurements as of
 
September 30, 2017
Measured on a Recurring Basis
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Securities available‑for‑sale:
 
 
 
 
 
 
 
Residential MBS and CMOs:
 
 
 
 
 
 
 
Agency MBS
$
377,541

 
$

 
$
377,541

 
$

Agency CMOs
175,950

 

 
175,950

 

Private label CMOs
134,550

 

 
96,614

 
37,936

Municipal securities
1,549,150

 

 
1,549,150

 

Agency commercial MBS
995,914

 

 
995,914

 

Corporate debt securities
19,125

 

 
19,125

 

Collateralized loan obligations
19,176

 

 
19,176

 

SBA securities
168,028

 

 
168,028

 

Asset-backed and other securities
92,796

 
4,808

 
45,603

 
42,385

Total securities available-for-sale
3,532,230

 
4,808

 
3,447,101

 
80,321

Equity warrants
5,158

 

 

 
5,158

Other derivative assets
1,221

 

 
1,221

 

Total recurring assets
$
3,538,609

 
$
4,808

 
$
3,448,322

 
$
85,479

Derivative liabilities
$
564

 
$

 
$
564

 
$

 
Fair Value Measurements as of
 
December 31, 2016
Measured on a Recurring Basis
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Securities available‑for‑sale:
 
 
 
 
 
 
 
Residential MBS and CMOs:
 
 
 
 
 
 
 
Agency MBS
$
502,443

 
$

 
$
502,443

 
$

Agency CMOs
146,289

 

 
146,289

 

Private label CMOs
125,469

 

 
68,567

 
56,902

Municipal securities
1,456,459

 

 
1,456,459

 

Agency commercial MBS
547,692

 

 
547,692

 

Corporate debt securities
47,509

 

 
47,509

 

Collateralized loan obligations
156,887

 

 
156,887

 

SBA securities
178,845

 

 
178,845

 

Asset-backed and other securities
62,237

 
2,080

 
51,784

 
8,373

Total securities available-for-sale
3,223,830

 
2,080

 
3,156,475

 
65,275

Equity warrants
5,497

 

 

 
5,497

Other derivative assets
694

 

 
694

 

Total recurring assets
$
3,230,021

 
$
2,080

 
$
3,157,169

 
$
70,772

Derivative liabilities
$
3,285

 
$

 
$
3,285

 
$


During the nine months ended September 30, 2017, there were no transfers of assets between Level 1 and Level 2, and there was a $0.7 million transfer of assets from Level 3 to Level 1 of the fair value hierarchy for assets measured on a recurring basis.
The following table presents information about quantitative inputs and assumptions used to determine the fair values provided by our third party pricing service for our Level 3 private label CMOs and asset-backed securities available-for-sale measured at fair value on a recurring basis as of the date indicated:
 
September 30, 2017
 
Private Label CMOs
 
Asset-Backed Securities
 
 
 
Weighted
 
 
 
Weighted
 
Range
 
Average
 
Range
 
Average
Unobservable Inputs
of Inputs
 
Input
 
of Inputs
 
Input
Voluntary annual prepayment speeds
3.2% - 25.5%
 
9.6%
 
5% - 15%
 
13.5%
Annual default rates
0.1% - 13.6%
 
2.2%
 
1% - 2%
 
1.8%
Loss severity rates
4.0% - 95.9%
 
46.9%
 
10% - 60%
 
52.4%
Discount rates
1.6% - 9.9%
 
4.6%
 
3.2% - 4.3%
 
3.6%



The following table presents information about quantitative inputs and assumptions used in the modified Black-Scholes option pricing model to determine the fair value for our Level 3 equity warrants measured at fair value on a recurring basis as of the date indicated:
 
September 30, 2017
 
Equity Warrants
 
Weighted
 
Average
Unobservable Inputs
Input
Volatility
17.3%
Risk-free interest rate
1.7%
Remaining life assumption (in years)
3.8

The following table summarizes activity for our Level 3 private label CMOs available-for-sale, asset-backed securities available-for-sale, and equity warrants measured at fair value on a recurring basis for the period indicated:
 
Private
 
Asset-Backed
 
Equity
 
Label CMOs
 
Securities
 
Warrants
 
(In thousands)
Balance, December 31, 2016
$
56,902

 
$
8,373

 
$
5,497

Total included in earnings
2,114

 
314

 
1,701

Total included in other comprehensive income
(578
)
 
(349
)
 

Purchases

 
37,722

 

Issuances

 

 
720

Sales
(4,732
)
 

 
(2,106
)
Net settlements
(15,770
)
 
(3,675
)
 

Transfers to securities available-for-sale

 

 
(654
)
Balance, September 30, 2017
$
37,936

 
$
42,385

 
$
5,158


The following tables present assets measured at fair value on a non‑recurring basis as of the dates indicated:
 
Fair Value Measurement as of
 
September 30, 2017
Measured on a Non‑Recurring Basis
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Impaired Non‑PCI loans
$
63,463

 
$

 
$
6,779

 
$
56,684

OREO
9,100

 

 
9,100

 

Total non-recurring
$
72,563

 
$

 
$
15,879

 
$
56,684

 
Fair Value Measurement as of
 
December 31, 2016
Measured on a Non‑Recurring Basis
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Impaired Non‑PCI loans
$
149,749

 
$

 
$
1,661

 
$
148,088

OREO
11,224

 

 
11,224

 

Investments carried at cost
242

 

 

 
242

Total non-recurring
$
161,215

 
$

 
$
12,885

 
$
148,330


The following table presents losses recognized on assets measured on a nonrecurring basis for the periods indicated:
 
Three Months Ended
 
Nine Months Ended
Losses on Assets
September 30,
 
September 30,
Measured on a Non‑Recurring Basis
2017
 
2016
 
2017
 
2016
 
(In thousands)
Impaired Non‑PCI loans
$
4,427

 
$
12,935

 
$
17,895

 
$
27,301

OREO

2,124

 

 
2,124

 

Total losses
$
6,551

 
$
12,935

 
$
20,019

 
$
27,301


The following table presents the valuation methodology and unobservable inputs for Level 3 assets measured at fair value on a nonrecurring basis as of the date indicated:
 
 
September 30, 2017
 
 
 
 
Valuation
 
Unobservable
 
 
 
Weighted
Asset
 
Fair Value
 
Technique
 
Inputs
 
Range
 
Average
 
 
(In thousands)
 
 
 
 
 
 
 
 
Impaired Non-PCI loans
 
$
55,365

 
Discounted cash flows
 
Discount rates
 
2.00% - 8.93%
 
6.84%
 
 
1,319

 
Third party appraisals
 
No discounts
 
 
 
 
Total non-recurring Level 3
 
$
56,684

 
 
 
 
 
 
 
 

ASC Topic 825, “Financial Instruments,” requires disclosure of the estimated fair value of certain financial instruments and the methods and significant assumptions used to estimate such fair values. Additionally, certain financial instruments and all nonfinancial instruments are excluded from the applicable disclosure requirements.
The following tables present carrying amounts and estimated fair values of certain financial instruments as of the dates indicated:
 
September 30, 2017
 
Carrying
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
147,579

 
$
147,579

 
$
147,579

 
$

 
$

Interest‑earning deposits in financial institutions
122,439

 
122,439

 
122,439

 

 

Securities available‑for‑sale
3,532,230

 
3,532,230

 
4,808

 
3,447,101

 
80,321

Investment in FHLB stock
17,250

 
17,250

 

 
17,250

 

Investments carried at cost
1,006

 
10,702

 

 

 
10,702

Loans and leases held for investment, net
15,530,911

 
15,700,815

 

 
6,779

 
15,694,036

Equity warrants
5,158

 
5,158

 

 

 
5,158

Other derivative assets
1,221

 
1,221

 

 
1,221

 

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 
 
 
 
 
 
 
 
 
Core deposits
13,531,300

 
13,531,300

 

 
13,531,300

 

Non-core non-maturity deposits
1,118,694

 
1,118,694

 

 
1,118,694

 

Time deposits
2,123,251

 
2,114,655

 

 
2,114,655

 

Borrowings
250,399

 
250,399

 
250,000

 
399

 

Subordinated debentures
448,126

 
431,173

 

 
431,173

 

Derivative liabilities
564

 
564

 

 
564

 

 
December 31, 2016
 
Carrying
 
Estimated Fair Value
 
Amount
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In thousands)
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and due from banks
$
337,965

 
$
337,965

 
$
337,965

 
$

 
$

Interest‑earning deposits in financial institutions
81,705

 
81,705

 
81,705

 

 

Securities available‑for‑sale
3,223,830

 
3,223,830

 
2,080

 
3,156,475

 
65,275

Investment in FHLB stock
21,870

 
21,870

 

 
21,870

 

Investments carried at cost
1,416

 
3,843

 

 

 
3,843

Loans and leases held for investment, net
15,298,716

 
15,494,808

 

 
1,661

 
15,493,147

Equity warrants
5,497

 
5,497

 

 

 
5,497

Other derivative assets
694

 
694

 

 
694

 

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 
 
 
 
 
 
 
 
 
Core deposits
12,523,834

 
12,523,834

 

 
12,523,834

 

Non-core non-maturity deposits
1,174,487

 
1,174,487

 

 
1,174,487

 

Time deposits
2,172,290

 
2,166,187

 

 
2,166,187

 

Borrowings
905,812

 
905,838

 
591,000

 
314,838

 

Subordinated debentures
440,744

 
424,507

 

 
424,507

 

Derivative liabilities
3,285

 
3,285

 

 
3,285

 


For information regarding the valuation methodologies used to measure our assets recorded at fair value (under ASC Topic 820), and for estimating fair value for financial instruments not recorded at fair value (under ASC Topic 825), see Note 1. Nature of Operations and Summary of Significant Accounting Policies, and Note 13. Fair Value Measurements, to the Consolidated Financial Statements of the Company's 2016 Annual Report on Form 10-K.
Limitations
Fair value estimates are made at a specific point in time and are based on relevant market information and information about the financial instrument. These estimates do not reflect income taxes or any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Because no market exists for a portion of the Company’s financial instruments, fair value estimates are based on what management believes to be reasonable judgments regarding expected future cash flows, current economic conditions, risk characteristics of various financial instruments, and other factors. These estimated fair values are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. Since the fair values have been estimated as of September 30, 2017, the amounts that will actually be realized or paid at settlement or maturity of the instruments could be significantly different.